AFM
SLS icon

Anson Funds Management’s SELLAS Life Sciences SLS Stock Holding History

Anson Funds Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,032,938
Closed -$9.71M – 162
2025
Q3 		$9.71M Buy
6,032,938
+5,757,938
+2,094% +$10.3M 0.88% 25
2025
Q2 		$602K Sell
275,000
-7,304,095
-96% -$11.2M 0.09% 87
2025
Q1 		$8.19M Buy
7,579,095
+6,386,829
+536% +$7.58M 1.49% 20
2024
Q4 		$1.24M Buy
1,192,266
+398,431
+50% +$455K 0.13% 86
2024
Q3 		$992K Buy
+793,835
New +$970K 0.1% 110
2024
Q2 		– Sell
-4,832,368
Closed -$4.88M – 187
2024
Q1 		$4.88M Buy
+4,832,368
New +$4.06M 0.32% 36
2019
Q3 		– Sell
-9,275
Closed -$52 – 47
2019
Q2 		$52 Buy
+9,275
New +$329K 0.03% 37

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return